SUMATRIPTAN SUCCINATE

Product Description

NAME :- SUMATRIPTAN SUCCINATE

IUPAC NAME :- 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide

CAS NO. :- 103628-48-4

FORMULA :- C18H27N3O6S

SYNONYMS :- gr43175c;SuMitrex;Sumatriptan succinate;methanesulfonamide(1:1);SuMatriptan Succinate, EP;SUMATRIPTANSUCCINATE(1:1);Sumatriptan Succinate (200 mg);3-[2-(DIMETHYLAMINO) ETHYL]-N-METHYL-1H-INDOLE-5-METHANE SULFONAMIDE;compd.with3-(2-(dimethylamino)ethyl)-n-methyl-1h-indole-5-butanedioicaci;3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl-N-methylmethanesulfonamide Succinate

APPLICATION :- A selective 5-HT1 receptor agonist

DESCRIPTION :- Sumatriptan succinate is a selective 5-HT1 receptor agonist with specificity towards 5-HT1D, 5-HT1B and 5-HT1A. In addition, the physicochemical properties of Sumatriptan succinate can be characterized using FT-IR, HPLC, SEM and XRD. It has been reported that Sumatriptan succinate can be produced via reactive precipitation without the presence of surfactants. Further studies show that molecules of Sumatriptan succinate are carried through cells using liposomes, with positively charged liposomes exhibiting the highest loading efficiency.